First Safety and Efficacy Data with the Radiohybrid<sup>177</sup>Lu-rhPSMA-10.1 for the Treatment of Metastatic Prostate Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

First Safety and Efficacy Data with the Radiohybrid¹⁷⁷Lu-rhPSMA-10.1 for the Treatment of Metastatic Prostate Cancer

Published:2023-12-21 Issue: Volume: Page:jnumed.123.266741
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Dierks Alexander,Gäble Alexander,Rinscheid Andreas,Wienand Georgine,Pfob Christian H.,Kircher Malte,Enke Johanna S.,Janzen Tilman,Patt Marianne,Trepel Martin,Weckermann Dorothea,Bundschuh Ralph A.,Lapa Constantin

Publisher

Society of Nuclear Medicine

Subject

Radiology, Nuclear Medicine and imaging

Reference23 articles.

1. Radiohybrid Ligands: A Novel Tracer Concept Exemplified by 18F- or 68Ga-Labeled rhPSMA Inhibitors

2. Diagnostic performance and safety of positron emission tomography with 18F-rhPSMA-7.3 in patients with newly diagnosed unfavourable intermediate to very high-risk prostate cancer: results from a phase 3, prospective, multicentre study (LIGHTHOUSE);Surasi;Eur Urol.,2023

3. Diagnostic performance and safety of 18F-rhPSMA-7.3 PET in men with suspected prostate cancer recurrence: results from a phase 3, prospective, multicenter study (SPOTLIGHT);Jani;J Urol.,2023

4. Preclinical evaluation of a novel radioligand therapy for patients with prostate cancer: biodistribution and efficacy of 177Lu-rhPSMA-10.1 in comparison with 177Lu-PSMA-I&T [abstract];Foxton;J Nucl Med.,2022

5. Enhanced therapeutic response to 177Lu-rhPSMA-10.1 in pre-clinical models of prostate cancer [abstract];Vassileva;J Nucl Med.,2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP